ClinSpec Dx

ClinSpec Diagnostics Ltd is a pre-spinout company based at the University of Strathclyde, who are developing the world’s first cost-effective blood test for the early detection of brain cancers. The current diagnostic pathway for brain cancers results in delayed diagnosis, contributing to the worst survival rates of any cancer. The ClinSpec Dx™ Triage ID system, using revolutionary SIRE Technology™, will allow clinicians to triage and fast-track patients for urgent brain scans. The technology is a platform for blood tests for other cancer and disease, as well as non-clinical applications, providing a pipeline of future products